• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>International Journal of Accounting, Finance and Risk Management >Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016
【24h】

Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016

机译：影响印度制药公司排名的财务预测指标2016

获取原文
       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The Indian Pharma industry is on a robust growth path and is likely to be in the top 10 global markets in value term by 2020. Indian pharmaceutical sector accounts for about 2.4 percent of the global pharmaceutical industry in value terms and 10 percent in volume terms and it is expecting to expand at a Compound Annual Growth Rate of 15.92 per cent to US$ 55 billion by 2020. By 2016-17, India is expecting to be the third-largest global generic Active Pharmaceutical Ingredient merchant market. This study seeks to describe the status of Indian pharmaceutical companies, their position, ranking, financial status and forecasting of future opportunities based on the financial predictors i.e. Net sales, total share capital net profit, total assets, total income. The ranking of the top 10 companies' changes drastically when they ranked based on total share capital and net profit. The financial stability of the companies can be described as they contribute more in market capitalization but are lagging behind in the ranking based on net profits and total share capital.
机译：印度制药业正处于强劲的增长道路上，到2020年，其产值可能会跻身全球十大市场。按价值计算，印度制药业约占全球制药业的2.4％，在数量上占10％，预计到2020年，印度的复合年增长率将达到15.92％，达到550亿美元。到2016-17年，印度有望成为全球第三大仿制药活性成分全球商人市场。本研究旨在根据财务预测指标（即净销售额，总股本净利润，总资产，总收入）来描述印度制药公司的状况，地位，排名，财务状况以及对未来机会的预测。当根据总股本和净利润排名时，排名前10位的公司的排名将发生巨大变化。公司的财务稳定性可以描述为它们在市值中贡献更大，但在基于净利润和总股本的排名中却落后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号